Literature DB >> 22584124

Impact of patient and program factors on default during treatment of multidrug-resistant tuberculosis.

M T Gler1, L J Podewils, N Munez, M Galipot, M I D Quelapio, T E Tupasi.   

Abstract

SETTING: In the Philippines, programmatic treatment of drug-resistant tuberculosis (TB) was initiated by the Tropical Disease Foundation in 1999 and transitioned to the National TB Program in 2006.
OBJECTIVE: To determine patient and socio-demographic characteristics associated with default, and the impact of patient support measures on default.
DESIGN: Retrospective cohort analysis of 583 MDR-TB patients treated from 1999 to 2006.
RESULTS: A total of 88 (15%) patients defaulted from treatment. The median follow-up time for patients who defaulted was 289 days (range 1-846). In multivariate analysis adjusted for age, sex and previous TB treatment, receiving a greater number of treatment drugs (≥ 5 vs. 2-3 drugs, HR 7.2, 95%CI 3.3-16.0, P < 0.001) was significantly associated with an increased risk of default, while decentralization reduced the risk of default (HR 0.3, 95%CI 0.2-0.7, P < 0.001).
CONCLUSION: Improving access to treatment for MDR-TB through decentralization of care to centers near the patient's residence reduced the risk of default. Further research is needed to evaluate the feasibility, impact and cost-effectiveness of decentralized care models for MDR-TB treatment.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22584124      PMCID: PMC4616015          DOI: 10.5588/ijtld.11.0502

Source DB:  PubMed          Journal:  Int J Tuberc Lung Dis        ISSN: 1027-3719            Impact factor:   2.373


  11 in total

Review 1.  A systematic review of the cost and cost effectiveness of treatment for multidrug-resistant tuberculosis.

Authors:  Christopher Fitzpatrick; Katherine Floyd
Journal:  Pharmacoeconomics       Date:  2012-01       Impact factor: 4.981

2.  Community-based treatment of multidrug-resistant tuberculosis in Lima, Peru: 7 years of experience.

Authors:  Sonya Shin; Jennifer Furin; Jaime Bayona; Kedar Mate; Jim Yong Kim; Paul Farmer
Journal:  Soc Sci Med       Date:  2004-10       Impact factor: 4.634

3.  Nationwide drug resistance survey of tuberculosis in the Philippines.

Authors: 
Journal:  Int J Tuberc Lung Dis       Date:  2009-04       Impact factor: 2.373

4.  Risk factors and mortality associated with default from multidrug-resistant tuberculosis treatment.

Authors:  Molly F Franke; Sasha C Appleton; Jaime Bayona; Fernando Arteaga; Eda Palacios; Karim Llaro; Sonya S Shin; Mercedes C Becerra; Megan B Murray; Carole D Mitnick
Journal:  Clin Infect Dis       Date:  2008-06-15       Impact factor: 9.079

5.  Default from tuberculosis treatment programme in Sagamu, Nigeria.

Authors:  O J Daniel; O T Oladapo; O K Alausa
Journal:  Niger J Med       Date:  2006 Jan-Mar

6.  Ambulatory treatment of multidrug-resistant pulmonary tuberculosis patients at a chest clinic.

Authors:  H J Kim; Y P Hong; S J Kim; W J Lew; E G Lee
Journal:  Int J Tuberc Lung Dis       Date:  2001-12       Impact factor: 2.373

7.  Treating multidrug-resistant tuberculosis in Tomsk, Russia: developing programs that address the linkage between poverty and disease.

Authors:  S Keshavjee; I Y Gelmanova; A D Pasechnikov; S P Mishustin; Y G Andreev; A Yedilbayev; J J Furin; J S Mukherjee; M L Rich; E A Nardell; P E Farmer; J Y Kim; S S Shin
Journal:  Ann N Y Acad Sci       Date:  2007-10-22       Impact factor: 5.691

8.  Self-administered, standardized regimens for multidrug-resistant tuberculosis in South Korea.

Authors:  S K Park; W C Lee; D H Lee; C D Mitnick; L Han; K J Seung
Journal:  Int J Tuberc Lung Dis       Date:  2004-03       Impact factor: 2.373

9.  DOTS-Plus for multidrug-resistant tuberculosis in the Philippines: global assistance urgently needed.

Authors:  T E Tupasi; M I D Quelapio; R B Orillaza; C Alcantara; N R C Mira; M R Abeleda; V T Belen; N M Arnisto; A B Rivera; E R Grimaldo; J O Derilo; W Dimarucut; M Arabit; D Urboda
Journal:  Tuberculosis (Edinb)       Date:  2003       Impact factor: 3.131

10.  Prevalence and predictors of default from tuberculosis treatment in Hong Kong.

Authors:  M Chan-Yeung; K Noertjojo; C C Leung; S L Chan; C M Tam
Journal:  Hong Kong Med J       Date:  2003-08       Impact factor: 2.227

View more
  15 in total

1.  Outcomes of multidrug-resistant tuberculosis in Zambia: a cohort analysis.

Authors:  Nathan Kapata; Martin P Grobusch; Gershom Chongwe; Pascalina Chanda-Kapata; William Ngosa; Mathias Tembo; Shebba Musonda; Patrick Katemangwe; Matthew Bates; Peter Mwaba; Alimuddin Zumla; Frank Cobelens
Journal:  Infection       Date:  2017-08-04       Impact factor: 3.553

2.  Improving outcomes for multi-drug-resistant tuberculosis in the Peruvian Amazon - a qualitative study exploring the experiences and perceptions of patients and healthcare professionals.

Authors:  Thomas W McNally; Gilles de Wildt; Graciela Meza; Connie M D Wiskin
Journal:  BMC Health Serv Res       Date:  2019-08-22       Impact factor: 2.655

3.  Map the gap: missing children with drug-resistant tuberculosis.

Authors:  C M Yuen; C A Rodriguez; S Keshavjee; M C Becerra
Journal:  Public Health Action       Date:  2015-03-21

4.  Access to Bacteriologic-Based Diagnosis in Smear Positive Retreatment Tuberculosis Patients in Rural China: A Cross-Sectional Study in Three Geographic Varied Provinces.

Authors:  Changming Zhou; Weili Jiang; Li Yuan; Wei Lu; Jinge He; Qi Zhao; Biao Xu
Journal:  PLoS One       Date:  2016-01-11       Impact factor: 3.240

Review 5.  Decentralized care for multidrug-resistant tuberculosis: a systematic review and meta-analysis.

Authors:  Jennifer Ho; Anthony L Byrne; Nguyen N Linh; Ernesto Jaramillo; Greg J Fox
Journal:  Bull World Health Organ       Date:  2017-08-01       Impact factor: 9.408

6.  Patient and Provider Reported Reasons for Lost to Follow Up in MDRTB Treatment: A Qualitative Study from a Drug Resistant TB Centre in India.

Authors:  Rajesh D Deshmukh; D J Dhande; Kuldeep Singh Sachdeva; Achuthan Sreenivas; A M V Kumar; Srinath Satyanarayana; Malik Parmar; Patrick K Moonan; Terrence Q Lo
Journal:  PLoS One       Date:  2015-08-24       Impact factor: 3.240

7.  Patterns of treatment interruption among patients with multidrug-resistant TB (MDR TB) and association with interim and final treatment outcomes.

Authors:  Laura Jean Podewils; Maria Tarcela S Gler; Maria Imelda Quelapio; Michael P Chen
Journal:  PLoS One       Date:  2013-07-29       Impact factor: 3.240

8.  Risk factors associated with default from multi- and extensively drug-resistant tuberculosis treatment, Uzbekistan: a retrospective cohort analysis.

Authors:  Maeve K Lalor; Jane Greig; Sholpan Allamuratova; Sandy Althomsons; Zinaida Tigay; Atadjan Khaemraev; Kai Braker; Oleksander Telnov; Philipp du Cros
Journal:  PLoS One       Date:  2013-11-06       Impact factor: 3.240

9.  Factors Associated with Loss to Follow-up during Treatment for Multidrug-Resistant Tuberculosis, the Philippines, 2012-2014.

Authors:  Thelma E Tupasi; Anna Marie Celina G Garfin; Ekaterina V Kurbatova; Joan M Mangan; Ruth Orillaza-Chi; Leilani C Naval; Glenn I Balane; Ramon Basilio; Alexander Golubkov; Evelyn S Joson; Woo-Jin Lew; Vivian Lofranco; Mariquita Mantala; Stuart Pancho; Jesus N Sarol
Journal:  Emerg Infect Dis       Date:  2016-03       Impact factor: 6.883

10.  Where there is hope: a qualitative study examining patients' adherence to multi-drug resistant tuberculosis treatment in Karakalpakstan, Uzbekistan.

Authors:  Shona Horter; Beverley Stringer; Jane Greig; Akhmet Amangeldiev; Mirzagaleb N Tillashaikhov; Nargiza Parpieva; Zinaida Tigay; Philipp du Cros
Journal:  BMC Infect Dis       Date:  2016-07-28       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.